Celliance Corporation - - BioPharm International

ADVERTISEMENT

Celliance Corporation

BioPharm International
Volume 18, Issue 12

Company Description



Celliance offers an expanding array of bioprocessing products and services including diagnostic products, cell culture media supplements, and contract manufacturing services. The company's customers include many of the leading biopharmaceutical companies worldwide who have brought FDA-approved products to the market using Celliance's products and technologies. Celliance's products help accelerate the movement of critical therapeutic drugs from the laboratory to the marketplace. Celliance is a Serologicals company based in Atlanta, GA.

Facilities

Located in North America and the United Kingdom, the company's manufacturing facilities represent a quality commitment to our customers. The Kankakee, IL, Toronto, Canada, and Lawrence, KS facilities produce a variety of proteins and other supplements used in diagnostic reagents and cell culture media. The company's facility in Scotland develops and manufactures monoclonal antibodies for use in diagnostic products.

Products

The EX-CYTE growth enhancement media supplement provides a balanced profile of metabolic factors proven to enhance cell growth and protein production in a variety of mammalian cells.



Probumin BSA: With over 30 application-specific grades of bovine albumin, Celliance is one of the world's largest and most experienced manufacturer of high quality bovine albumin.

Incelligent Insulin: Celliance is the leading provider of Incelligent recombinant human insulin to the bioprocessing industry.

MonoSera Monoclonal Antibodies

Celliance is a leading manufacturer of monoclonal antibodies for the blood-typing industry. Celliance has over 60 monoclonal antibodies and over 20 years of expertise in the manufacture of monoclonal antibodies and finished blood-typing reagents.

CELLIANCE CORPORATION
5655 Spalding Drive Norcross, GA 30092

TELEPHONE
North America: 800.431.4505
All Others: 678.728.2246

FAX
North America: 800.468.7436
All Others: 678.728.2247

E-MAIL

WEB ADDRESS
http://www.celliancecorp.com/

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines
Source: BioPharm International,
Click here